HomeEVOK • NASDAQ
Follow
Evoke Pharma Inc
Previous close
$0.61
Day range
$0.59 - $0.65
Year range
$0.56 - $2.42
Market cap
5.14M USD
Avg Volume
49.77K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 1.68M | 110.45% |
Operating expense | 3.50M | 51.33% |
Net income | -1.99M | -10.21% |
Net profit margin | -118.58 | 47.63% |
Earnings per share | -0.59 | -11.32% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 4.74M | -51.85% |
Total assets | 7.07M | -40.36% |
Total liabilities | 9.65M | 24.22% |
Total equity | -2.58M | — |
Shares outstanding | 8.48M | — |
Price to book | -0.79 | — |
Return on assets | -63.26% | — |
Return on capital | -143.89% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -1.99M | -10.21% |
Cash from operations | -1.11M | 55.87% |
Cash from investing | — | — |
Cash from financing | -119.30K | — |
Net change in cash | -1.23M | 51.11% |
Free cash flow | -381.10K | 80.72% |
About
Founded
2007
Headquarters
Website
Employees
4